Systematic review and meta-analysis of 8 RCTs and 8 observational studies: semaglutide was associated with higher NAION risk only in observational diabetes data (26.7 vs 18.9 per 100,000 person-years; HR 1.85); RCTs and weight-loss studies showed no significant increase.
Meta-analysisn = 1,642,452
Liu et al. Rate and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy with Semaglutide Use for Diabetes and Weight Loss: A Systematic Review and Meta-Analysis